and e. Absorptions indicated that these antigens were present on mature granulocytes but absent from platelets, lymphocytes, monocytes, and myeloid precursors. A single antigen of another separate locus, HGA-1, was also identified. Absorptions revealed a quite different distribution for HGA-1 than HGA-3, this antigen being detected on monocytes and myeloblasts as well as on mature granulocytes. Independent segregation of the three loci from HLA, from the NA-NB and the 5a-5b antigens, and from themselves was confirmed in informative families.
INTRODUCTION
Recent widespread use of granulocyte transfusions to support patients with severe chemotherapy-induiced neutropenia, and the sharp increase in bone marrow transplantation have reawakened interest in the sturface antigens on granulocytes and their precursors. Substantial evidence exists that the concentration of HLA-A and HLA-B antigens on granulocytes is conlsiderably less than on lymphocytes (1, 2) . Despite a number of investigations, no beneficial or harmful effect of the transftusion of HLA minsmatched granulocytes into sensitized recipients has been conclusively demonstrated (3) (4) (5) .
Granulocytes possess unique antigens that have been demonstrated primarily by leukoagglutination tests, i.e., NA,, NA2, and NB1 (6, 7) 9a (8) and more recently by both agglutination and indirect immunofluorescence, i.e., ND1 (9) and NE1 (10) . Although many of the antisera detecting these specificities have been obtained from patients suffering from neonatal or acquired immunoneutropenia, there has also been no report to date that mismatching for human granulocyte antigens has been a negative factor in either granulocyte transfusion therapy or in bone marrow transplantation (3) (4) (5) 11) . Therefore, we have set out to systematically search for additional antigens involving granulocytes that may serve as clinically important determinants in these and other conditions. Recently, we have provisionally reported evidence for more than one new granulocyte system detected by a double fluorochromatic mnicrogranulocytotoxic assay (12, 13) .
This report extends those observationis and describes a new polymorphic locus with genes coding for antigenis that are confined to mature granulocytes with at least five alleles. These studies also provide evidence for other antigens that are shared by granulocytes and monocytes. METHODS Granulocytotoxicity (GCY) . 1 The double fluorochromatic microgranulocytotoxicity method has been previously reported in detail (14) . Minor modifications at one ofthe centers (Leiden) involved substitutions of 5% Dextran (200,000 mol wt, Poviet, Amsterdam) in phosphate-buffered saline for 2% methylcellulose-15 (278, Fisher Scientific Co., Pittsburgh, Pa.) for erythrocyte sedimentation; 1% bovine serum albumin in phosphate-buffered saline in place of tris-buffered saline (0.9% NaCl buffered with 0.001 M Tris-HCl, pH 7.2) as the standard washing and diluent solution; and the substitution of 0.025 ,ug/ml carboxyfluorescein diacetate (kindly provided by Dr. were performed with 0.5% bovine serum albumin-HBSS chilled to 4°C. These modifications increased the cell yield, reduced clumping, and improved viability. The percentage of monocytes in the nonadherent and adherent samples was estimated by alphanaphthyl butyrase staining (16) . The concentration of monocytes was 86+±4% in the adherent aliquot and <0.5% in the non-adherent aliquot. The performance of the monocytotoxicity and nonadherent lymphocytotoxicity (LCY) tests thereafter was identical to the method for fluorochromatic GCY.
Antisera. Several hundred samples of serum were examined from multigravida females, patients experiencing febrile transfusion reactions, recipients of multiple granulocyte transfusions, and from individuals suffering from either neonatal or acquired immunoneutropenia. The best antisera were generally selected from this prescreening on the basis of tentative clustering and strength of reactivity. Several index sera were tested against panels of 50 or more cells on three occasions to check reproducibility and the validity of the tentative clusters.
Immunoglobulin class. To determine the immunoglobulin (Ig) class of granulocyte antibodies, the technique of antibody neutralization by anti-Ig reagents (17) was performed except that it was not necessary to remove the neutralized Ig-anti-Ig precipitates by ultracentrifugation. After incubation of 1.0 ,/l antiserum with 1.0 ,lI of either goat F(ab')2 anti-human IgM, or IgG for 30 min at 37°C, known positive or negative cells were added and the cytotoxicity test continued as described above. The Ig class was determined by which anti-Ig reagent caused a positive reaction to become negative.
Cell donors. Normal cell donors completely characterized for HLA-A, -B, -C; NA,, NA2, NB; and 5a-5b (antigens independent of HLA present on granulocytes, lymphocytes, and platelets) (18, 19) constituted the cell panels at both institutions. The population study involving 98 unrelated normal donors was performed at one institution. In addition, families were tested at both institutions, all of which were characterized for HLA-A, -B, -C, and -DRw and many of which were also typed for NA,, NA2, NB1, and 5a-5b. Patients were not included in the family analysis. Absorptions. Absorptions were performed with isolated granulocytes, T and B, lymphocytes, platelets, myeloblasts from patients with acute myelocytic leukemia, and enriched monocytes. The sera were first titrated to determine the last two-fold dilution giving a strongly positive reaction. One dilution stronger than this endpoint was absorbed for 30 to 60 min at 23°C with 5.0-6.0 x 106 cells/100 ,ul except for platelets in which case absorptions were performed two times with 0.5 vol of packed platelets to serum.
Statistical methods. Two-by-two contingency tables were prepared from all possible serum pairs and for all serum-antigen combinations. Based on these tables, chi-square (x2) for independence (with Yate's correction) and correlation coefficients (r = were calculated.
The fit of the observed and expected phenotype combination (which is a test of Hardy-Weinberg equilibrium) were tested for significance using K. Pearson's chi-square formula (20) . Gene frequencies (GF) were calculated from the observed phenotype frequency (PF): GF = 1 -V/1-PF; expected heterozygosity was calculated by the formula: E = (GFi x GF;) x 2 x the number of cells tested (n), where i, j, etc.
= antigens being tested; and X2 = J(O -E)2/E, where 0 = observed heterozygosity. In this analysis, the number of degrees of freedom (d.f.) is equal to the number of phenotype classes, minus 1 for the (-/-) combination, minus 1 for each antigen/-combination, and minus 1 for each time that expectations are pooled.
RESULTS
Initial antisera screening. In the early phases of this study, sera were collected from many sources and screened for LCY, GCY, and granulocyte agglutinating reactivity. Several hundred sera were examined from 224 patients including sequential samples taken before, during, and after multiple granulocyte transfusion therapy. In addition, sera from 32 normal male and female controls were also analyzed (Table I) . Whereas neither agglutinating nor cytotoxic antibodies were commonly present in the control sera, including samples from multiparous females, the incidence rose strikingly in blood-transfusion patients. The highest frequency, however, occurred in patients suffering from idiopathic symptomatic immunoneutropenia and recipients of multiple granulocyte transfusions. Antibodies reactive with grannulocytes were detected in over 50% of these samples, but the incidence of LCY antibodies was low in both groups.
In 10 patients with severe secondary drug-induced neutropenia, no antibodies were detected before the onset of supportive granulocyte transfusions (Table II) . Sequential samples during and after these transfusions were obtained and revealed the appearance of granulocyte antibody from 1 to 72 d after completion of the transfusion therapy. An additional interesting observation is that only one patient of this group developed antilymphocyte antibodies. A typical sequence is illustrated with another patient (MOO) whose sera have proved to be an excellent reagent detecting one of the alleles of a new granulocyte locus to be described below. Although agglutinins were never observed, GCY antibody first appeared at the end of 20 transftisions. The strength of the antibody rose to a titer of 1:4 within another 2 wk, remained constant for 3 mo and declined in the following 3.5 mo. The Ig class responsible for the cytotoxicity was investigated by neutralization with F(ab')2 heavy chain-specific antiIgM, IgG (17) , and found to be IgG in all samples from this patient. These same characteristics with re- Preliminary clusters. After the initial screening to identify prospective reagents, secondary screens involving 53-67 unrelated normal cell donors were performed to test for provisional clusters. In addition, 2 x 2 chi-squares and correlation coefficients for experimental sera, HLA-A, -B, -C; NA,, NA2, NB, and 5a-5b antigenic phenotypes were used to cluster sera with similar reactivity patterns. Several clusters have been identified. The first was defined by three antisera derived from two recipients of multiple granulocyte transfusions (WRI and ROO) and an individual with immunoneutropenia (CON). This cluster has been termed Human Granulocyte Antigen-i (HGA-1, Table III).
On the other hand, five other provisional clusters have been identified by three or more sera in most cases. The initial observations with three of these clusters revealed not only their internal positive correlations, but also the fact that the correlation coefficients among sera from different clusters were often 3a/3d 1/-RUG (a representative ofa group of sera that have been obtained from immunoneutropenics and bone marrow transplantation recipients) reacted with both granulocytes and monocytes (Table VII) . There were no significant correlations between the HGA-1 and HGA-3 antigens and the HLA, NA-NB, or 5a-5b phenotypes of the unrelated cell donors.
Finally, 12 families (both parents plus at least two children) have been studied to determine whether or not the new granulocyte antigens segregate independently of HLA. Six of the families were also typed for NA,, NA2, NB1, and 5a-5b by capillary with isolated granulocytes. All of the typing sera had been included in previous workshops and were considered to be strong monospecific reagents. One of these families (HSF) was highly informative because the father was homozygous for the uncommon 5a antigen, lacked NB1, and was homozygous for NA2 (Fig. 2 ). There were four children divided into two male and female HLAidentical pairs, i.e., A2,B5/A2-B15 and A3,B35/Al,B13. One of each pair inherited the maternal antigen. In addition, its inheritance could also be distinguished from maternal NB1, 5a, or 5b. Similarly, there was independent segregation ofpaternal HGA-3d and HGA-3e from NB1 and NA2 but it was not possible in this family to establish independence of these granulocyte antigens from paternal HLA or 5a inheritance. Evidence for independence of HGA-1 from the other antigenic systems was clarified by the facts that one each of the HLA-identical pairs inherited the paternal HGA-1, these two individuals differed for HGA-3d and HGA-3e and, in both cases, HGA-1 caused a triplet to occur.
The second family (RHM) also provided evidence for the independence of HGA-1 from the HGA-3 locus and from HLA (Fig. 3) . Again, there were two pairs of HLA identical sibs, i.e., A29,B12/A3,B7 and Aw32,-B14/Ai,B8 plus two other sibs that had inherited the other two alternatives, i.e., Aw32,B14/A3,B7 and A29,B12/Al,B8. Therefore, it was possible to determine independent segregation of HGA-3a, 3e, and 3c from HLA: paternal HGA-3a was detected in at least one member of each of the HLA identical pairs that differed for their paternal haplotypes; HGA-3e was present in one individual with paternal A29,B12 and in the other with Aw32,B14; similarly, HGA-3c was inherited by sibs with different mnuaternal haplotypes.
This family also confirms the independence of these loci from NA,, in this case detected by GCY. Two aspects of GCY have proven to be a great advantage in demonstrating new granulocyte-specific antigens. Firstly, HLA antisera generally fail to react with mature granulocytes in cytotoxicity testing (14) , yet they may specifically react in capillary agglutination (26) and absorption may be accomnplished with high concentrations of granulocytes. Secondly, we have demonstrated that the same sera may exhibit quite different reaction patterns with the same granulocyte donors when tested by cytotoxicity as compared with agglutination (25) . LOM represents the only serum we have encountered that detects one of the neutrophil-specific NA antigens by cytotoxicity, yet its agglutination reactions are quite different. Thus, it has been possible to screen rather large numbers of sera for GCY without having to first absorb them with platelets or lymphocytes to remove anti-HLA antibodies. This position has been subsequently supported by the observations that GCY reactivity was not absorbed by lymphocytes or platelets.
It was with this background that we undertook the screening of large numbers of antisera in anticipation of finding reagents demonstrating new granulocyte antigens. This report describes a total of seven provisional granulocyte antigens. Of these, the group HGA-3 is particularly interesting because it appears to be the first polymorphic locus whose gene products are present on granulocytes. Recognizing that our sera are roughly comparable in quality to the early HLA reagents, it nevertheless has been possible to distinguish five specificities that satisfy the criteria for allelism in that calculations for goodness of fit were well within the limits of significance. They did not form an unacceptable number of triplets and they segregated as alleles of one locus in informative f;amilies. The combined gene frequency of the five HGA-3 specificities is only 0.7231. This could indicate either that the antisera were too weak to detect all of their potential targets or, more likely, it suggests that other alleles may be found. The family studies support the latter hypothesis because segregation in three informative families, including family RHM, demonstrates that a fourth unidentified allele was present. It also seems possible, in light of the history of HLA serology, that subsequent sera may better define the identified antigens. Family segregation studies document that HGA-3 is not apparently associated with HLA nor with the NA-NB or 5a-5b an-tigens. Absorption studies indicated that the HGA-3 antigens were present only on mature granulocytes, making them comparable in that regard to the neutrophil-specific NA-NB antigens (6, 7) .
Another granulocyte antigen, termed HGA-1, was different in several aspects from HGA-3: goodness of fit calculations and triplet counting in the unrelated population study plus clearly independent segregation in the family studies distinguish it from HGA-3 and this was confirmed by the demonstration of the HGA-1 antigen on both immature and mature granulocytes and on monocytes. Furthermore, parallel HGA-1 reactions were detected on both monocytes and granulocytes from the same cell donors whereas the HGA-3 antisera that have been so tested have reacted only with granulocytes. This may represent one of several granulocyte-monocyte antigens since we have observed sera obtained from a variety of multiparous, transftised, bone marrow transplanted, and immunoneutropenic patients that react with both types of cells. Serum AYD is an example in which both the granulocyte and monocyte activity may be absorbed by either cell type from positive donors but was not absorbed by platelets, lymphoid cell lines, or chronic lymphatic leukemia cells (27) . These absorptions exclude the possibility of shared monocyte-B lymphocyte antigens.
Recently, we have also demonstrated that this serum reacts with cord endothelial cells, raising the question as to whether the non-B cell monocyte-endothelial antigens described by may also be expressed on granulocytes.
What, if any, relationship do the antigens described herein bear to the preliminary human granulocyte specificities reported by Hasegawa et 
